Michigan 18th Annual Advanced Liver Disease and Liver Transplantation Update 2024

Michigan 18th Annual Advanced Liver Disease and Liver Transplantation Update 2024

Regular price
$25.00
Sale price
$25.00
Regular price
Sold out
Unit price
per 

Michigan Medicine 18th Annual Advanced Liver Disease and Liver Transplantation Update 2024

Format: 10 videos + 1 pdf, size: 4.06 GB

Course Audience: gastroenterologists, internists, family medicine physician, primary care physician, surgeon

Overview:

This course is to provide an update on recent developments in the management of patients with advanced liver disease including recent improvements in the management of Metabolic Associated liver disease, GI and Hepatic side effects immunotherapy, and use of TIPS for complications of portal hypertension. In addition, updates on MELD 3.0 in liver transplantation allocation, managing alcohol use disorder, assessment and management of frail LT candidates, how to assess coronary artery disease in patients with cirrhosis, and the use of extracorporeal machine perfusion of donor livers will be provided. After completing this activity, participants will understand and be able to implement in their practice recent developments in the management of patients with advanced liver disease.

This activity is appropriate for:

House Officers, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, Physicians, Social Workers

In the fields of:

Family Medicine, Gastroenterology, General Medicine, Hepatology, Internal Medicine, Primary Care, Surgery, Transplant Surgery

Learning Objectives

At the end of this activity, participant will understand and be able to implement:

  • Newer approaches to the use of weight loss agents and other medications in patients with metabolic associated liver disease
  • Appropriate diagnostic tools and treatment strategies for patients with Immunotherapy related colitis and hepatitis
  • How and when to place a TIPS for cirrhotics with GI bleeding and refractory ascites
  • Use of the MELD 3.0 scoring system in liver transplant candidates
  • How to assess and treat malnutrition and fraility in patients with advanced cirrhosis
  • How to diagnose and treat coronary artery disease and valvular heart disease in patients with cirrhosis
  • Potential use of normothermic and hypothermic perfusion of livers in the transplant setting

 

18thannualliverroundup2024010924_0111_101946 (PDF Format)

Assessment and Management of Frail Liver Transplant Candidates (Video MP4 Format)

Checkpoint Inhibitor Hepatitis & Colitis (Video MP4 Format)

Diagnosis and Treatment of Coronary Artery Disease and Valvular Heart Disease in Cirrhosis (Video MP4 Format)

Interactive Case 1- A Transplant Candidate with AUD (Video MP4 Format)

Machine Perfusion of Donor Organs (Video MP4 Format)

Managing Alcohol Use Disorder (AUD) in ALD Patients (Video MP4 Format)

MELD 3.0 in Liver Transplantation (Video MP4 Format)

Panel Questions & Answers Part 1 Q&A (MASLD, Immunotherapy, Portal Hypertension, Liver Allocation, Alcohol Use Disorder) (Video MP4 Format)

TIPS for Complications of Portal Hypertension (Video MP4 Format)

Weight Loss Agents & Medical Therapy for MASLD (Video MP4 Format)